Glendora, California Clinical Trials

A listing of Glendora, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 46 clinical trials
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancers type are NSCLC and melanoma that are progressing …

endometrial adenocarcinoma
endometrioid adenocarcinoma of the endometrium
non-small cell lung cancer
hepatitis b surface antigen
stage iv non-small cell lung cancer
City of Hope Medical Center
 (4.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +8 other locations
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

ki-ras
kras
solid tumor
kras g12c mutation
metastatic malignant solid tumor
City of Hope Comprehensive Cancer Center
 (4.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +7 other locations
A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX130 in subjects with relapsed or refractory renal cell carcinoma.

carcinoma
renal cell carcinoma
karnofsky performance status
Research Site 2
 (4.6 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

This phase III trial studies how well a telehealth self-management program works in improving survivorship care and outcomes in stage I-III non-small cell lung cancer or colorectal cancer survivors. Survivor self-management program focuses on coaching patients on follow-up care after cancer treatments. Participating in the program may improve knowledge and …

colorectal cancer
non-small cell lung cancer
stage iia colorectal cancer ajcc v8
small cell lung cancer
stage i colorectal cancer ajcc v8
City of Hope Medical Center
 (4.6 away) Contact site
  • 4 views
  • 16 Feb, 2024
  • 1 location
First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Primary Objective: To determine the maximum tolerated dose (MTD) of SAR442257 administered as a single agent in patients with relapsed and refractory multiple myeloma (RRMM) and refractory non-Hodgkin lymphoma (RR-NHL), and determine the recommended Phase 2 dose (RP2D) Secondary Objectives: To characterize the safety profile of SAR442257 To characterize the …

diffuse large b-cell lymphoma
dexamethasone
cutaneous t-cell lymphoma
core needle biopsy
chronic lymphocytic leukemia
Investigational Site Number 8400001
 (4.6 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +4 other locations
First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Primary Objectives: Dose Escalation Part A: To determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or refractory multiple myeloma (RRMM), and determine the recommended Phase 2 dose (RP2D) for the subsequent Expansion Part B Dose Expansion Part B: To assess the …

refractory multiple myeloma
carfilzomib
autologous hematopoietic stem cell transplant
line of therapy
ixazomib
Investigational Site Number 8400002
 (4.6 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +7 other locations